ZDZhongyang Ding

Zhongyang Ding

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects


Zhongyang Ding has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Guangjie Sheng

    Emergency Center, The Affiliated Wuxi People’s Hospital, Nanjing Medical University, Wuxi, China

    1 shared publication
  • Guorong Huang

    Emergency Center, The Affiliated Wuxi People’s Hospital, Nanjing Medical University, Wuxi, China

    1 shared publication
  • Jiaming Zhang

    Emergency Center, The Affiliated Wuxi People’s Hospital, Nanjing Medical University, Wuxi, China

    1 shared publication
  • Jinyu Xu

    Emergency Center, The Affiliated Wuxi People’s Hospital, Nanjing Medical University, Wuxi, China

    1 shared publication

Latest Publications

  • Propofol Administration Modulates AQP-4 Expression and Brain Edema After Traumatic Brain Injury

    by Zhongyang Ding, Jiaming Zhang, Jinyu Xu, Guangjie Sheng, Guorong Huang

    The increased intracranial pressure caused by brain edema following traumatic brain injury (TBI) always leads to poor patient prognosis. Aquaporin-4 (AQP-4) plays an important role in edema formation and resolution, which may provide a novel therapeutic target for edema treatment. In this present study, we found that propofol treatment, within a short time, after TBI significantly reduced brain edema in a controlled cortical injury rat model and suppressed in vivo expression of AQP-4. The ameliorating effect of propofol was associated with attenuated expression of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α). In addition, the regulatory effect of propofol on AQP-4 expression was investigated in cultured astrocytes. Results showed that propofol could block the stimulatory effect of IL-1β and TNF-α on AQP-4 expression in cultured astrocytes. We also found that both NFκB and p38/MAPK pathways were involved in IL-1β and TNF-α-induced AQP-4 expression and that propofol functions as a dual inhibitor of NFκB and p38/MAPK pathways. In conclusion, treatment with propofol, within a short time, after TBI attenuates cerebral edema and reduces the expression of AQP-4. Propofol modulates acute AQP-4 expression by attenuating IL-1β and TNF-α expression and inhibiting IL-1β and TNF-α induced AQP-4 expression.